3 products found

advanceCOR GmbH products

advanceCOR - GPVI-Inhibitory Antibodies

Our GPVI-inhibiting antibodies follow a completely new mode of action. They prevent activation of blood platelets and are thus supposed to protect against heart attacks and strokes. They have proven their high specificity and effectiveness in animal models without increased bleeding complications.

advanceCOR - Cyclic Peptides

This is a new type of drug for the treatment of thyroid diseases and the complications they cause in the heart and eye.

advanceCOR Revacept - Synthetic Protein

This is the name of our therapeutic agent for the prevention of stroke and heart attack. Its principle effectiveness has already been proven in patients. It is a soluble protein which, when blood vessels are damaged, covers the damaged areas. Revacept is designed to protect the vessel walls so that vascular occlusion does not occur. Revacept has been shown to be well tolerated and effective in a Phase II study in carotid artery damage and heart damage. Further studies are in preparation and modified Revacept products are in pre-clinical research.